ORBIMED ADVISORS LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$9.1B
Holdings
170
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (170 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 6,028,307 | $382.4B | 4202.90% | |
| 2 | PRLDPRELUDE THERAPEUTICS INC | 10,039,691 | $313.7B | 3447.95% | |
| 3 | HZNPHORIZON THERAPEUTICS PUB L | 2,610,355 | $285.9B | 3142.41% | |
| 4 | MRKMERCK & CO INC | 3,732,400 | $280.3B | 3080.90% | |
| 5 | BMYBRISTOL-MYERS SQUIBB CO | 4,515,400 | $267.2B | 2936.22% | |
| 6 | BSXBOSTON SCIENTIFIC CORP | 5,833,600 | $253.1B | 2781.74% | |
| 7 | MRTXEURMIRATI THERAPEUTICS INC | 1,373,200 | $242.9B | 2669.79% | |
| 8 | EWTXEDGEWISE THERAPEUTICS INC | 13,944,680 | $231.5B | 2543.95% | |
| 9 | IVVDADAGIO THERAPEUTICS INC | 5,383,500 | $227.4B | 2499.07% | |
| 10 | PMVPPMV PHARMACEUTICALS INC | 7,330,423 | $218.4B | 2400.69% | |
| 11 | IMAPRELUDE THERAPEUTICS INC | 5,680,186 | $177.5B | 1950.76% | |
| 12 | NTRANATERA INC | 1,572,800 | $175.3B | 1926.22% | |
| 13 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,645,100 | $163.9B | 1800.88% | |
| 14 | VRTXVERTEX PHARMACEUTICALS INC | 877,400 | $159.2B | 1749.05% | |
| 15 | —TURNING POINT THERAPEUTICS I | 2,361,327 | $156.9B | 1723.90% | |
| 16 | GHGUARDANT HEALTH INC | 1,227,400 | $153.4B | 1686.25% | |
| 17 | ABBVABBVIE INC | 1,420,600 | $153.2B | 1684.08% | |
| 18 | UNHUNITEDHEALTH GROUP INC | 389,700 | $152.3B | 1673.43% | |
| 19 | ARQTARCUTIS BIOTHERAPEUTICS INC | 6,073,850 | $145.1B | 1594.67% | |
| 20 | ISRGINTUITIVE SURGICAL INC | 139,600 | $138.8B | 1525.20% | |
| 21 | XBISPDR SER TR | 1,065,700 | $134.0B | 1472.30% | |
| 22 | HUMHUMANA INC | 335,000 | $130.4B | 1432.69% | |
| 23 | EWEDWARDS LIFESCIENCES CORP | 1,126,400 | $127.5B | 1401.42% | |
| 24 | DC4DEXCOM INC | 228,000 | $124.7B | 1370.25% | |
| 25 | NBIXNEUROCRINE BIOSCIENCES INC | 1,192,015 | $114.3B | 1256.42% | |
| 26 | GRCLGRACELL BIOTECHNOLOGIES INC | 7,884,870 | $109.4B | 1201.88% | |
| 27 | ZBHZIMMER BIOMET HOLDINGS INC | 660,800 | $96.7B | 1062.88% | |
| 28 | SYKSTRYKER CORPORATION | 337,400 | $89.0B | 977.86% | |
| 29 | —KINNATE BIOPHARMA INC | 3,847,929 | $88.6B | 973.47% | |
| 30 | SPRYSILVERBACK THERAPEUTICS INC | 8,740,887 | $87.2B | 958.69% | |
| 31 | RPTXREPARE THERAPEUTICS INC | 3,322,488 | $87.2B | 958.11% | |
| 32 | IMGNEURIMMUNOGEN INC | 14,897,914 | $84.5B | 928.32% | |
| 33 | ABCLABCELLERA BIOLOGICS INC | 4,180,768 | $83.8B | 920.76% | |
| 34 | XTNTXTANT MED HLDGS INC | 72,873,494 | $80.9B | 888.97% | |
| 35 | IMAIKENA ONCOLOGY INC | 6,215,466 | $78.4B | 862.03% | |
| 36 | SVASINOVAC BIOTECH LTD | 2,839,500 | $78.4B | 861.60% | |
| 37 | ELVANTHEM INC | 207,100 | $77.2B | 848.49% | |
| 38 | JANXJANUX THERAPEUTICS INC | 3,466,386 | $75.0B | 823.99% | |
| 39 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 2,183,143 | $74.2B | 815.26% | |
| 40 | ETNBGBP89BIO INC | 3,729,442 | $73.1B | 802.92% | |
| 41 | PGNYPROGYNY INC | 1,270,045 | $71.1B | 781.63% | |
| 42 | PASGPASSAGE BIO INC | 6,962,899 | $69.3B | 762.14% | |
| 43 | CRSPCRISPR THERAPEUTICS AG | 612,700 | $68.6B | 753.68% | |
| 44 | KROSKEROS THERAPEUTICS INC | 1,679,417 | $66.4B | 730.14% | |
| 45 | BIIBBIOGEN INC | 234,200 | $66.3B | 728.36% | |
| 46 | NPCENEUROPACE INC | 4,012,281 | $63.6B | 698.90% | |
| 47 | CRNXCRINETICS PHARMACEUTICALS IN | 2,996,876 | $63.1B | 693.28% | |
| 48 | TMOTHERMO FISHER SCIENTIFIC INC | 110,300 | $63.0B | 692.56% | |
| 49 | TORCEURADICET BIO INC | 7,232,856 | $56.7B | 623.19% | |
| 50 | OSH3EUROAK STR HEALTH INC | 1,328,300 | $56.5B | 620.85% | |
| 51 | MGTXMEIRAGTX HLDGS PLC | 4,102,925 | $54.1B | 594.30% | |
| 52 | ORICORIC PHARMACEUTICALS INC | 2,337,574 | $48.9B | 537.17% | |
| 53 | SIBNSI-BONE INC | 2,248,000 | $48.2B | 529.18% | |
| 54 | HCAHCA HEALTHCARE INC | 193,800 | $47.0B | 516.95% | |
| 55 | ERASERASCA INC | 2,167,341 | $46.0B | 505.43% | |
| 56 | SEMSELECT MED HLDGS CORP | 1,271,100 | $46.0B | 505.27% | |
| 57 | SGENUSDSEAGEN INC | 268,000 | $45.5B | 500.10% | |
| 58 | 1T7TRICIDA INC | 9,614,280 | $44.6B | 490.26% | |
| 59 | TBPHTHERAVANCE BIOPHARMA INC | 5,895,159 | $43.6B | 479.42% | |
| 60 | NVLSEURALPINE IMMUNE SCIENCES INC | 4,081,592 | $43.6B | 478.62% | |
| 61 | MREOMEREO BIOPHARMA GROUP PLC | 17,264,764 | $41.8B | 459.17% | |
| 62 | TELATELA BIO INC | 3,027,542 | $41.4B | 454.50% | |
| 63 | CTKBCYTEK BIOSCIENCES INC | 1,923,139 | $41.2B | 452.49% | |
| 64 | —VECTIVBIO HLDG AG | 5,123,304 | $39.6B | 434.96% | |
| 65 | TERNTERNS PHARMACEUTICALS INC | 3,791,204 | $39.5B | 434.14% | |
| 66 | —LOGICBIO THERAPEUTICS INC | 8,466,783 | $38.8B | 426.16% | |
| 67 | —DECIBEL THERAPEUTICS INC | 4,945,192 | $38.1B | 419.01% | |
| 68 | GLPGGALAPAGOS NV | 723,457 | $38.1B | 418.28% | |
| 69 | APLTAPPLIED THERAPEUTICS INC | 2,257,387 | $37.5B | 411.82% | |
| 70 | —IKENA ONCOLOGY INC | 2,933,941 | $37.0B | 406.91% | |
| 71 | VTGNUSDVISTAGEN THERAPEUTICS INC | 12,909,283 | $35.4B | 388.72% | |
| 72 | CRVSCORVUS PHARMACEUTICALS INC | 6,943,654 | $33.6B | 369.33% | |
| 73 | BNRBURNING ROCK BIOTECH LTD | 1,856,201 | $33.2B | 364.74% | |
| 74 | —SIERRA ONCOLOGY INC | 1,477,320 | $32.4B | 355.88% | |
| 75 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 4,015,524 | $31.9B | 350.83% | |
| 76 | SCPHSCPHARMACEUTICALS INC | 4,797,148 | $31.9B | 350.59% | |
| 77 | GHRSGH RESEARCH PLC | 1,428,666 | $31.5B | 346.36% | |
| 78 | VRNAVERONA PHARMA PLC | 5,694,841 | $31.2B | 342.97% | |
| 79 | FLBFLUIDIGM CORP DEL | 4,599,571 | $30.3B | 333.11% | |
| 80 | CYBNEURCYBIN INC | 13,447,121 | $29.5B | 323.79% | |
| 81 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,578,174 | $28.6B | 313.94% | |
| 82 | —CURIS INC | 3,521,400 | $27.6B | 303.02% | |
| 83 | —MERSANA THERAPEUTICS INC | 2,888,847 | $27.2B | 299.38% | |
| 84 | NSTGEURNANOSTRING TECHNOLOGIES INC | 556,000 | $26.7B | 293.36% | |
| 85 | PCVXVAXCYTE INC | 1,034,665 | $26.2B | 288.47% | |
| 86 | CGEMCULLINAN ONCOLOGY INC | 1,146,145 | $25.9B | 284.28% | |
| 87 | —FUSION PHARMACEUTICALS INC | 3,224,770 | $25.5B | 280.68% | |
| 88 | GRPHGRAPHITE BIO INC | 1,449,904 | $23.8B | 261.16% | |
| 89 | —GEMINI THERAPEUTICS INC | 5,826,224 | $23.5B | 258.68% | |
| 90 | AFIBACUTUS MED INC | 2,648,386 | $23.4B | 257.29% | |
| 91 | TCE2CELLDEX THERAPEUTICS INC NEW | 414,300 | $22.4B | 245.82% | |
| 92 | —SINGULAR GENOMICS SYSTEMS IN | 1,998,521 | $22.4B | 245.77% | |
| 93 | OLMAOLEMA PHARMACEUTICALS INC | 807,792 | $22.3B | 244.67% | |
| 94 | CTIC1USDCTI BIOPHARMA CORP | 7,520,600 | $22.2B | 243.82% | |
| 95 | THCTENET HEALTHCARE CORP | 311,700 | $20.7B | 227.59% | |
| 96 | —HARPOON THERAPEUTICS INC | 2,611,308 | $20.6B | 226.71% | |
| 97 | GILDGILEAD SCIENCES INC | 287,600 | $20.1B | 220.77% | |
| 98 | JNCEEURJOUNCE THERAPEUTICS INC | 2,655,600 | $19.7B | 216.84% | |
| 99 | QUREUNIQURE NV | 585,574 | $18.7B | 205.99% | |
| 100 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $18.5B | 203.28% |
Page 1 of 2Next